作者
SR Raman, KKC Man, S Bahmanyar, A Berard, S Bilder, T Boukhris, G Bushnell, S Crystal, K Furu, YH Kao Yang, Ø Karlstad, H Kieler, K Kiyoshi Kubota, ECC Lai, JE Martikainen, G Maura, N Moore, D Montero, H Nakamura, A Neumann, V Pate, A Pottegård, NL Pratt, EE Roughead, D Macias Saint-Gerons, T Stürmer, CC Su, H Zoega, MCJM Sturkenbroom, EW Chan, D Coghill, Ip P, ICK Wong
发表日期
2018/9/14
期刊
Lancet Psychiatry
简介
Background
The use of medications to treat attention deficit hyperactivity disorder (ADHD) has increased, but the prevalence of ADHD medication use across different world regions is not known. Our objective was to determine regional and national prevalences of ADHD medication use in children and adults, with a specific focus on time trends in ADHD medication prevalence.
Methods
We did a retrospective, observational study using population-based databases from 13 countries and one Special Administrative Region (SAR): four in Asia and Australia, two in North America, five in northern Europe, and three in western Europe. We used a common protocol approach to define study populations and parameters similarly across countries and the SAR. Study populations consisted of all individuals aged 3 years or older between Jan 1, 2001, and Dec 31, 2015 (dependent on data availability). We estimated annual …
学术搜索中的文章
SR Raman, KKC Man, S Bahmanyar, A Berard… - The Lancet Psychiatry, 2018
SR Raman, KKC Man, P Ip - Lancet Psychiatry, 2018